MultiOmic Health has received $6.2 million in funding
MultiOmic Health, an AI-enabled drug discovery firm, has raised a £5 million (US$6.2 million) seed investment extension round to enhance its precision medicines discovery platform for metabolic syndrome-related medical disorders. Hoxton Ventures led the investment, with Ada Ventures, MMC Ventures, and Verve Ventures also participating. MultiOmic has funded a total of US$8.6 million since its … Read more